Advanced search
Publication Cover
OncoImmunology Volume 4, 2015 - Issue 3
Submit an article Journal homepage
1,226
Views
8
CrossRef citations to date
0
Altmetric
Author's View

Targeting tumor-associated myeloid cells for cancer immunotherapy

Hong QinDepartment of Lymphoma and Myeloma; The University of Texas MD Anderson Cancer Center; Houston, TX, USA;Center for Cancer Immunology Research; The University of Texas MD Anderson Cancer Center; Houston, TX, USACorrespondence[email protected] [email protected]
,
Guowei WeiDepartment of Lymphoma and Myeloma; The University of Texas MD Anderson Cancer Center; Houston, TX, USA;Center for Cancer Immunology Research; The University of Texas MD Anderson Cancer Center; Houston, TX, USA
,
Dongho GwakDepartment of Lymphoma and Myeloma; The University of Texas MD Anderson Cancer Center; Houston, TX, USA;Center for Cancer Immunology Research; The University of Texas MD Anderson Cancer Center; Houston, TX, USA
,
Zhenyuan DongDepartment of Lymphoma and Myeloma; The University of Texas MD Anderson Cancer Center; Houston, TX, USA;Center for Cancer Immunology Research; The University of Texas MD Anderson Cancer Center; Houston, TX, USA
,
Ailian XiongDepartment of Lymphoma and Myeloma; The University of Texas MD Anderson Cancer Center; Houston, TX, USA;Center for Cancer Immunology Research; The University of Texas MD Anderson Cancer Center; Houston, TX, USA
&
Larry W KwakDepartment of Lymphoma and Myeloma; The University of Texas MD Anderson Cancer Center; Houston, TX, USA;Center for Cancer Immunology Research; The University of Texas MD Anderson Cancer Center; Houston, TX, USACorrespondence[email protected] [email protected]
Article: e983961 | Received 07 Oct 2014, Accepted 31 Oct 2014, Published online: 02 Apr 2015

References

  • Dave S.S, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, Fisher RI, Braziel RM, Rimsza LM, Grogan TM et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004 351, 2159-69; PMID:15548776; http://dx.doi.org/10.1056/NEJMoa041869
  • Qin, H, Lerman B, Sakamaki I, Wei G, Cha SC, Rao SS, Qian J, Hailemichael Y, Nurieva R, Dwyer KC et al. Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice. Nat Med 2014 20, 676-81; PMID:24859530; http://dx.doi.org/10.1038/nm.3560
  • Gabrilovich DI , Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009 9, 162-74; PMID:19197294; http://dx.doi.org/10.1038/nri2506
  • Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, Mandruzzato S, Bronte V. Myeloid-derived suppressor cell heterogeneity and subset definition. Curr Opin Immunol 2010 22, 238-44; PMID:20171075; http://dx.doi.org/10.1016/j.coi.2010.01.021
  • Gorgun GT, Whitehill G, Anderson JL, Hideshima T, Maguire C, Laubach J, Raje N, Munshi NC, Richardson PG, Anderson KC. Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans. Blood 2013 121, 2975-87; PMID:23321256; http://dx.doi.org/10.1182/blood-2012-08-448548
  • Filipazzi P, Valenti R, Huber V, Pilla L, Canese P, Iero M, Castelli C, Mariani L, Parmiani G, Rivoltini L. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J Clin Oncol 2007 25, 2546-53; PMID:17577033; http://dx.doi.org/10.1200/JCO.2006.08.5829
  • Bendandi M, Gocke CD, Kobrin CB, Benko FA, Sternas LA, Pennington R, Watson TM, Reynolds CW, Gause BL, Duffey PL et al. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nat Med 1999 5, 1171-7; PMID:10502821; http://dx.doi.org/10.1038/13928
  • Schuster SJ, Neelapu SS, Gause BL, Janik JE, Muggia FM, Gockerman JP, Winter JN, Flowers CR, Nikcevich DA, Sotomayor EM et al. Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma. J Clin Oncol 2011 29, 2787-94; PMID:21632504; http://dx.doi.org/10.1200/JCO.2010.33.3005
  • Kim K, Skora AD, Li Z, Liu Q, Tam AJ, Blosser RL, Diaz LA Jr, Papadopoulos N, Kinzler KW, Vogelstein B et al. Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells. Proc Natl Acad Sci U S A 2014 111, 11774-9; PMID:25071169; http://dx.doi.org/10.1073/pnas.1410626111
  • Zhao F, Hoechst B, Duffy A, Gamrekelashvili J, Fioravanti S, Manns MP, Greten TF, Korangy F. S100A9 a new marker for monocytic human myeloid-derived suppressor cells. Immunology 2012 136, 176-83; PMID:22304731; http://dx.doi.org/10.1111/j.1365-2567.2012.03566.x

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.